Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02361606
Other study ID # 2009108
Secondary ID
Status Completed
Phase N/A
First received February 3, 2015
Last updated February 6, 2015
Start date March 2009
Est. completion date January 2013

Study information

Verified date February 2015
Source Sheba Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Interventional

Clinical Trial Summary

Adolescents are often reluctant to receive psychological help. The investigators developed a web-based cognitive behavioral self-help intervention for adolescents with type 1 diabetes. The investigators aimed to examine the participation rate and outcomes on glycemic control and quality of life.


Description:

Adolescents are often reluctant to receive psychological help. The investigators developed a web-based cognitive behavioral self-help intervention for adolescents with type 1 diabetes. The investigators aimed to examine the participation rate and outcomes on glycemic control and quality of life.

Single center study was conducted to describe participation and efficacy of internet cognitive-behavioral intervention for youth with type 1 diabetes. Adolescents with type 1 diabetes, aged 13-20 years, treated at a Juvenile Diabetes Center, were offered to participate in the intervention. Recruitment period lasted for 2 months, during January-February, 2011.

HbA1c measures of adolescents that agreed to participate, were obtained from medical records.The adolescents, that logged in, were asked to complete questionnaires before the intervention assessing their expectations of the program, quality of life and parental support. After completion of questionnaires, the adolescents were encouraged to complete 6 virtual sessions. Satisfaction was assessed after each session. In the end of the program, participants were asked again to complete questionnaires. HbA1c levels were obtained again for participants that logged in, and for participants that passively refused, 3 months or more after the recruitment.


Recruitment information / eligibility

Status Completed
Enrollment 89
Est. completion date January 2013
Est. primary completion date February 2011
Accepts healthy volunteers No
Gender Both
Age group 13 Years to 20 Years
Eligibility Inclusion Criteria:

- diagnosis with diabetes for at least 1 year

- treated at Juvenile Diabetes Center

- fluent Hebrew speakers

Exclusion Criteria:

- no previous diagnosis of a psychiatric condition (such as an eating disorder)

- no opposition to the internet due to religious issues.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
An Internet Cognitive-Behavioral Intervention
We developed a cognitive behavioral program for adolescents with type 1 Diabetes and their parents, that consists of six virtual sessions at https://minustress.com/diabetes/gate.asp.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Dr. Orit Hamiel Academic College of Tel Aviv-Jaffa, Maccabi Healthcare Services, Israel

Outcome

Type Measure Description Time frame Safety issue
Other Youth expectations of the program. (Questionnaire regarding the expectations of the possible benefits of the program.) Questionnaire regarding the expectations of the possible benefits of the program. Baseline No
Primary Change in quality of life. (Diabetes Quality of Life (DQOL) questionnaire) Filled in the intervention website. Change from baseline to the end of intervention (3 to 6 months from baseline) No
Primary Perceived parent support. (Short version of the Social Provision Scale) Short version of the Social Provision Scale -filled in the intervention website. Change from baseline to the end of intervention (3 to 6 monts) No
Primary Youth satisfaction of the program. (Questionnaire regarding the degree that the session was helpful.) Questionnaire regarding the degree that the session was helpful. Measured at the end of every virtual session (2 days to 6 months from baseline). No
Secondary Change in glycemic control. (HbaA1c levels, obtained from medical records) HbaA1c levels, obtained from medical records twice - the closest measurement available before the trial period, and closest measurement available 3 months or more after the trial period. Last HbA1C before recruitment period and first HbA1C after recruitment period were obtained from medical records (3-12 months from baseline). No
See also
  Status Clinical Trial Phase
Recruiting NCT05653518 - Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes N/A
Enrolling by invitation NCT05515939 - Evaluating the InPen in Pediatric Type 1 Diabetes
Completed NCT05109520 - Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Recruiting NCT04016987 - Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes N/A
Active, not recruiting NCT04190368 - Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes N/A
Recruiting NCT05413005 - Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus Early Phase 1
Active, not recruiting NCT04668612 - Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes N/A
Completed NCT02837094 - Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 Phase 1
Recruiting NCT05414409 - The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action Phase 2
Recruiting NCT05670366 - The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes N/A
Active, not recruiting NCT05418699 - Real-life Data From Diabetic Patients on Closed-loop Pumps
Completed NCT04084171 - Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 N/A
Recruiting NCT06144554 - Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Recruiting NCT05379686 - Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes N/A
Recruiting NCT05153070 - Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes Phase 2
Completed NCT05281614 - Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D Early Phase 1
Withdrawn NCT04259775 - Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes N/A
Active, not recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Completed NCT02855307 - Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes Phase 2
Completed NCT02897557 - Insulet Artificial Pancreas Early Feasibility Study N/A